Supplies of the Oxford University vaccine produced by AstraZeneca began expanding to General Practice (GP) led services in the UK from Thursday to make it easier to protect care home residents and other vulnerable people against Covid-19, the British Government said.
As part of a phased rollout since the jabs received regulatory approval last month, the vaccine has been trialled at selected hospitals
in the country for surveillance purposes before being sent out to hundreds of community-based local vaccination services.
“The biggest vaccination programme in NHS (National Health Service) history is already off to a strong start with around 1 million people already vaccinated against coronavirus - this is a credit to our exceptional NHS staff,” said Dr Nikki Kanani, GP and NHS medical director for primary care.
